FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Originally published by Ars Technica

The risk appears small and data is mixed, but FDA wants patients to be aware.
Original reporting
Read the full story at the original publisher
PulsePress is a news discovery platform. We bring headlines from multiple publishers together so you can discover stories in one place. The complete reporting remains with the original publisher.
Read original article →